Skip to main content

4 Result(s)

within Myke R. Green Remove this filter

and

  1. No Access

    Article

    Oxaliplatin-induced neuropathy: a tale of two electrolytes

    Hani M. Babiker, Myke R. Green, Mark A. Nelson, Emad Elquza in Supportive Care in Cancer (2015)

  2. No Access

    Article

    Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity

    The role of olanzapine added to a dopamine antagonist and benzodiazepine for the treatment of refractory chemotherapy-induced nausea and vomiting (CINV) is incompletely characterized in all levels of chemother...

    Sierra Vig, Laurel Seibert, Myke R. Green in Journal of Cancer Research and Clinical On… (2014)

  3. No Access

    Article

    High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma

    Primary central nervous system lymphoma (PCNSL) is a rare B-cell lymphoid neoplasm for which current regimens utilizing standard-dose chemotherapy and/or radiation therapy lead to high relapse rates and/or una...

    Christopher J. Campen, Rebecca L. Tombleson, Myke R. Green in Journal of Neuro-Oncology (2011)

  4. No Access

    Article

    Renal dysfunction during and after high-dose methotrexate

    To evaluate renal dysfunction in adult patients encountered during and immediately after repeated administrations of high-dose methotrexate (HDMTX) for treatment of primary central nervous system lymphoma (PCN...

    Myke R. Green, Marc C. Chamberlain in Cancer Chemotherapy and Pharmacology (2009)